Safety of topical corticosteroids in pregnancy: A population-based cohort study

Journal of Investigative Dermatology

Volumn 131, Issue 4, 2011, Pages 884-891

  Chi, Ching Chi ^a,b,d   Mayon White, Richard T ^c   Wojnarowska, Fenella T ^b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ARTICLE; CLEFT LIP; CLEFT LIP FACE PALATE; CLEFT PALATE; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; DOSE RESPONSE; DRUG SAFETY; ENVIRONMENTAL EXPOSURE; FEMALE; GROWTH RETARDATION; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SIDE EFFECT; SPONTANEOUS ABORTION; STILLBIRTH;

EID: 79952767818     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.392     Document Type: Article

References (32)

1. Ain R, Canham LN, Soares MJ (2005) Dexamethasone-induced intrauterine growth restriction impacts the placental prolactin family, insulin-like growth factor-II and the Akt signaling pathway. J Endocrinol 185:253-63 (Pubitemid 40691792)
2. Arosarena OA (2007) Cleft lip and palate. Otolaryngol Clin North Am 40:27-60 (Pubitemid 46343846)
3. Barker DJ (1999) Fetal origins of cardiovascular disease. Ann Med 31 (Suppl 1):3-6 (Pubitemid 29209697)
4. Barker DJ, Bull AR, Osmond C et al. (1990) Fetal and placental size and risk of hypertension in adult life. BMJ 301:259-62 (Pubitemid 20241224)
5. Barker DJ, Hales CN, Fall CH et al. (1993) Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36:62-7 (Pubitemid 23018337)
6. Brodsky D, Christou H (2004) Current concepts in intrauterine growth restriction. J Intensive Care Med 19:307-19 (Pubitemid 44544694)
7. Carmichael SL, Shaw GM, Ma C et al. (2007) Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol 197:585.e1-7
8. Chi CC (2009) Evidence-based assessment of the safety of topical corticosteroids in pregnancy. DPhil thesis, University of Oxford, Oxford
9. Chi CC, Lee CW, Wojnarowska F et al. (2009) Safety of topical corticosteroids in pregnancy. Cochrane Database Syst Rev (3):CD007346
10. Chung KC, Kowalski CP, Kim HM et al. (2000) Maternal cigarette smoking during pregnancy and the risk of having a child with cleft lip/palate. Plast Reconstr Surg 105:485-91 (Pubitemid 30110980)
11. Czeizel AE, Rockenbauer M (1997) Population-based case-control study of teratogenic potential of corticosteroids. Teratology 56:335-40 (Pubitemid 28035180)
12. De Jong van den Berg LT, Feenstra N, Sorensen HT et al. (1999) Improvement of drug exposure data in a registration of congenital anomalies. Pilot-study: pharmacist and mother as sources for drug exposure data during pregnancy. EuroMAP Group. European Medicine and Pregnancy Group. Teratology 60:33-6 (Pubitemid 29338853)
13. Edwards MJ, Agho K, Attia J et al. (2003) Case-control study of cleft lip or palate after maternal use of topical corticosteroids during pregnancy. Am J Med Genet A 120:459-63 (Pubitemid 37063739)
14. Gairdner D, Pearson J (1971) A growth chart for premature and other infants. Arch Dis Child 46:783-7
15. Gelfand JM, Dommasch ED, Shin DB et al. (2009) The risk of stroke in patients with psoriasis. J Invest Dermatol 129:2411-8
16. GPRD (2007) The Database. GPRD Division of the Medicines and Healthcare products Regulatory Agency (MHRA): London
17. Jick H, Jick SS, Derby LE (1991) Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 302:766-8
18. Jick SS, Kaye JA, Vasilakis-Scaramozza C et al. (2003) Validity of the general practice research database. Pharmacotherapy 23:686-9 (Pubitemid 36539051)
19. Källén B (2003) Maternal drug use and infant cleft lip/palate with special reference to corticoids. Cleft Palate Craniofac J 40:624-8 (Pubitemid 37429691)
20. Khoury MJ, James LM, Flanders WD et al. (1992) Interpretation of recurring weak associations obtained from epidemiologic studies of suspected human teratogens. Teratology 46:69-77
21. Mahé A, Perret JL, Ly F et al. (2007) The cosmetic use of skin-lightening products during pregnancy in Dakar, Senegal: a common and potentially hazardous practice. Trans R Soc Trop Med Hyg 101:183-7 (Pubitemid 44835343)
22. Mehta DK (ed) (2007) British National Formulary. BMJ Publishing Group Ltd and RPS Publishing: London
23. Mygind H, Thulstrup AM, Pedersen L et al. (2002) Risk of intrauterine growth retardation, malformations and other birth outcomes in children after topical use of corticosteroid in pregnancy. Acta Obstet Gynecol Scand 81:234-9 (Pubitemid 34264139)
24. Pradat P, Robert-Gnansia E, Di Tanna GL et al. (2003) First trimester exposure to corticosteroids and oral clefts. Birth Defects Res A Clin Mol Teratol 67:968-70 (Pubitemid 38018036)
25. Randhawa R, Cohen P (2005) The role of the insulin-like growth factor system in prenatal growth. Mol Genet Metab 86:84-90 (Pubitemid 41412163)
26. Romo A, Carceller R, Tobajas J (2009) Intrauterine growth retardation (IUGR): epidemiology and etiology. Pediatr Endocrinol Rev 6(Suppl 3): 332-6
27. Smith GC (2006) Predicting antepartum stillbirth. Curr Opin Obstet Gynecol 18:625-30 (Pubitemid 44747179)
28. Spilson SV, Kim HJ, Chung KC (2001) Association between maternal diabetes mellitus and newborn oral cleft. Ann Plast Surg 47:477-81 (Pubitemid 33049574)
29. Stanier P, Moore GE (2004) Genetics of cleft lip and palate: syndromic genes contribute to the incidence of non-syndromic clefts. Hum Mol Genet 13:R73-81 (Pubitemid 38443801)
30. Steer P (2005) The epidemiology of preterm labour. BJOG 112(Suppl 1):1-3 (Pubitemid 40313972)
31. UK (1992) Still-Birth (Definition) Act 1992. Her Majesty's Stationery Office: London
32. Wyszynski DF, Duffy DL, Beaty TH (1997) Maternal cigarette smoking and oral clefts: a meta-analysis. Cleft Palate Craniofac J 34:206-10 (Pubitemid 27220839)